Recursion Pharmaceuticals
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
117 of 143
Related slides by other companies
MAIA Biotechnology
Investor Presentation
January 2024
excellent efficacy in models liver cancer | MAIA Biotechnology
OKYO Pharma
Results
June 2023
validation efficacy in dry eye mouse model | OKYO Pharma
CARGO Therapeutics
IPO
March 2024
has increased activity in mouse tumor models with all antigens and with antigen loss | CARGO Therapeutics
Fusion Pharmaceuticals
IPO
June 2020
enhanced efficacy in a mouse tumor model | Fusion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights